Published in Neurobiol Aging on December 07, 2015
DCTN1 gene analysis in Chinese patients with sporadic amyotrophic lateral sclerosis. PLoS One (2017) 0.75
Quantitative analysis of the features of fasciculation potentials and their relation with muscle strength in amyotrophic lateral sclerosis. Neurol Sci (2016) 0.75
A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK. Brain (2017) 0.75
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. Lancet Neurol (2015) 5.50
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.33
Isolated transient myoclonus in the elderly: an under-recognized condition? Clin Neurol Neurosurg (2013) 2.04
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Mult Scler (2014) 1.85
Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain (2006) 1.57
Isolated unilateral oculomotor paresis in pure midbrain stroke. J Neurol Sci (2015) 1.50
Vertebral Artery Dissection Leading to Fornix Infarction: A Case Report. J Stroke Cerebrovasc Dis (2015) 1.41
Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One (2017) 1.40
The Neural Basis of Typewriting: A Functional MRI Study. PLoS One (2015) 1.39
A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics. BMC Neurol (2016) 1.38
High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism. Neurobiol Aging (2015) 1.16
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry (2015) 1.06
Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann Neurol (2016) 1.03
Human genetic variation database, a reference database of genetic variations in the Japanese population. J Hum Genet (2016) 1.00
Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses. J Hum Genet (2014) 0.92
A case of autism spectrum disorder arising from a de novo missense mutation in POGZ. J Hum Genet (2015) 0.92
First adult case of Helicobacter cinaedi meningitis. J Neurol Sci (2013) 0.91
Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci (2008) 0.90
EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. Parkinsonism Relat Disord (2014) 0.89
Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes. Muscle Nerve (2015) 0.89
Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis. BMJ Open (2014) 0.87
Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2014) 0.87
Cerebral dural sinus thrombosis associated with adenomyosis: a case report. J Stroke Cerebrovasc Dis (2014) 0.87
Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2015) 0.87
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis. J Neuroimmunol (2014) 0.86
Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry (2014) 0.86
Guillain-Barré syndrome in Asia. J Neurol Neurosurg Psychiatry (2013) 0.84
Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation. BMJ Open (2015) 0.83
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Mult Scler (2015) 0.83
Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open (2015) 0.82
Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci Res (2010) 0.82
Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. J Neurol Sci (2015) 0.81
De novo missense mutations in NALCN cause developmental and intellectual impairment with hypotonia. J Hum Genet (2016) 0.81
Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. J Neurol Neurosurg Psychiatry (2012) 0.81
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica. J Neuroimmunol (2015) 0.81
Perlecan is required for FGF-2 signaling in the neural stem cell niche. Stem Cell Res (2013) 0.80
Neural substrates of cognitive subtypes in Parkinson's disease: a 3-year longitudinal study. PLoS One (2014) 0.80
L-carnitine enhances axonal plasticity and improves white-matter lesions after chronic hypoperfusion in rat brain. J Cereb Blood Flow Metab (2014) 0.80
Novel mutations in the PNPLA6 gene in Boucher-Neuhäuser syndrome. J Hum Genet (2015) 0.80
[Spinocerebellar ataxia type 36 (nicknamed Asidan)]. Brain Nerve (2012) 0.80
Cerebral microbleeds are associated with worse cognitive function in the nondemented elderly with small vessel disease. Cerebrovasc Dis Extra (2014) 0.79
Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry (2014) 0.79
Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy? Case Rep Neurol (2014) 0.79
De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures. J Hum Genet (2016) 0.78
Serum high mobility group box 1 is upregulated in myasthenia gravis. J Neurol Neurosurg Psychiatry (2014) 0.78
Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry (2015) 0.78
Associations of durations of antiplatelet use and vascular risk factors with the presence of cerebral microbleeds. J Stroke Cerebrovasc Dis (2013) 0.78
Phase II Trial of Intravenous Low-Dose Granulocyte Colony-Stimulating Factor in Acute Ischemic Stroke. J Stroke Cerebrovasc Dis (2016) 0.78
Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study. J Neurol Sci (2015) 0.78
Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis. JAMA Neurol (2014) 0.77
Incidental diagnosis of an asymptomatic adult-onset Alexander disease by brain magnetic resonance imaging for preoperative evaluation. J Neurol Sci (2015) 0.77
Corrigendum to "The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons" [FEBS Open Bio 4 (2014) 1-10]. FEBS Open Bio (2014) 0.77
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter. Magn Reson Imaging (2014) 0.77
The frequency of cardiac valvular regurgitation in Parkinson's disease. Mov Disord (2008) 0.77
Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study. Parkinsonism Relat Disord (2014) 0.77
Limbic encephalitis associated with relapsing polychondritis responded to infliximab and maintained its condition without recurrence after discontinuation: a case report and review of the literature. Nagoya J Med Sci (2014) 0.77
Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English version. Mov Disord Clin Pract (2014) 0.77
Autophagy-mediated stress response in motor neurons after hypothermic spinal cord ischemia in rabbits. J Vasc Surg (2014) 0.77
Serum uric acid concentration is linked to wearing-off fluctuation in Japanese Parkinson's disease patients. J Parkinsons Dis (2014) 0.77
Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy. JAMA Neurol (2016) 0.77
Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes. PLoS One (2014) 0.77
Differential effect of HDAC3 on cytoplasmic and nuclear huntingtin aggregates. PLoS One (2014) 0.77
Cerebral organoids model human brain development and microcephaly. Mov Disord (2013) 0.77
Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sites. Diabetologia (2015) 0.77
Association of leptin with orthostatic blood pressure changes in Parkinson's disease. Mov Disord (2016) 0.77
First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China. PLoS One (2017) 0.77
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption. Mult Scler (2016) 0.76
Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis. J Neurol (2016) 0.76
Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis. JAMA Neurol (2015) 0.76
FBXO7 mutations in Parkinson's disease and multiple system atrophy. Neurobiol Aging (2016) 0.76
FUS/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice. Sci Rep (2016) 0.76
Adrenomedullin deficiency and aging exacerbate ischemic white matter injury after prolonged cerebral hypoperfusion in mice. Biomed Res Int (2014) 0.76
Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol (2016) 0.76
Lipid rafts involvement in the pathogenesis of Parkinson's disease. Front Biosci (Landmark Ed) (2015) 0.76
Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry (2016) 0.76
Cerebral infarction in a case of Parry-Romberg syndrome. J Stroke Cerebrovasc Dis (2013) 0.76
Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neurosci Res (2015) 0.76
Use of a Human Artificial Chromosome for Delivering Trophic Factors in a Rodent Model of Amyotrophic Lateral Sclerosis. Mol Ther Nucleic Acids (2015) 0.76
MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy. Mol Ther (2016) 0.76
Neuronal intranuclear inclusion disease presenting with resting tremor. Case Rep Neurol (2014) 0.76
Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. J Neurol Sci (2014) 0.76
Plasma Brain Natriuretic Peptide is a Marker of Prognostic Functional Outcome in Non-Cardioembolic Infarction. J Stroke Cerebrovasc Dis (2015) 0.75
An autopsy case of familial amyotrophic lateral sclerosis with a TARDBP Q343R mutation. Neuropathology (2015) 0.75
A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells. Neurotherapeutics (2016) 0.75
Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy. PLoS One (2016) 0.75
A Case of Painless Legs and Moving Toes Syndrome in Parkinson's Disease Responsive to Dopaminergic Therapy. Case Rep Neurol Med (2016) 0.75
Active brain changes after initiating fingolimod therapy in multiple sclerosis patients using individual voxel-based analyses for diffusion tensor imaging. Nagoya J Med Sci (2016) 0.75
P150glued-associated disorders are caused by activation of intrinsic apoptotic pathway. PLoS One (2014) 0.75
Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics. BMC Neurol (2017) 0.75
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis? J Neurol Neurosurg Psychiatry (2014) 0.75
Corticosteroid-responsive leptomeningitis with IgG4-positive plasma-cell infiltration. J Neurol Sci (2015) 0.75
Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons. Biochem Biophys Res Commun (2017) 0.75
Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease. PLoS One (2015) 0.75
Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.75